Overview

Long-term Extension Study of MCI-196

Status:
Terminated
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
The Primary Objectives of this study are to assess the long-term efficacy of treatment with colestilan (MCI-196) (including combination therapy) and to assess the long-term safety of treatment with colestilan (MCI-196) (including combination therapy).
Phase:
Phase 3
Details
Lead Sponsor:
Mitsubishi Tanabe Pharma Corporation